Processa Pharmaceuticals Inc. (PCSA) Misses Q3 EPS by 1c

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) reported Q3 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Processa Pharmaceuticals Inc. (PCSA) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Equinor ASA (ADR) (EQNR) PT Lowered to $37 at TD Cowen
• Piper Sandler's Weekly Focus Idea: Principal Financial Group (PFG)